BrightSpring Health Services (NASDAQ:BTSG) Cut to “Buy” at Wall Street Zen

Wall Street Zen downgraded shares of BrightSpring Health Services (NASDAQ:BTSG) from a strong-buy rating to a buy rating in a research report report published on Saturday morning.

A number of other analysts have also recently commented on the company. UBS Group upped their price objective on BrightSpring Health Services from $35.00 to $42.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. BTIG Research boosted their price target on BrightSpring Health Services from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of BrightSpring Health Services in a research report on Thursday. Deutsche Bank Aktiengesellschaft set a $30.00 price objective on shares of BrightSpring Health Services and gave the stock a “buy” rating in a report on Monday, September 8th. Finally, Cowen restated a “buy” rating on shares of BrightSpring Health Services in a research report on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $35.73.

BrightSpring Health Services Price Performance

Shares of NASDAQ:BTSG opened at $31.36 on Friday. The business has a fifty day moving average price of $30.20 and a 200-day moving average price of $25.11. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.79 and a quick ratio of 1.38. The company has a market capitalization of $5.66 billion, a PE ratio of 51.41, a PEG ratio of 0.54 and a beta of 2.41. BrightSpring Health Services has a 1-year low of $15.26 and a 1-year high of $35.01.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings data on Monday, October 20th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.03. BrightSpring Health Services had a return on equity of 11.61% and a net margin of 1.04%.The business had revenue of $3.33 billion for the quarter, compared to analysts’ expectations of $3.16 billion. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. FY 2025 guidance at EPS. As a group, equities analysts expect that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Jon B. Rousseau sold 235,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total transaction of $6,763,300.00. Following the sale, the insider directly owned 1,131,930 shares of the company’s stock, valued at $32,576,945.40. This represents a 17.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Lisa A. Nalley sold 20,000 shares of the stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total transaction of $575,600.00. Following the transaction, the insider owned 131,150 shares of the company’s stock, valued at $3,774,497. This trade represents a 13.23% decrease in their position. The SEC filing for this sale provides additional information. 3.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On BrightSpring Health Services

Several hedge funds and other institutional investors have recently modified their holdings of the business. T. Rowe Price Investment Management Inc. boosted its position in shares of BrightSpring Health Services by 264.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,772,772 shares of the company’s stock worth $104,430,000 after purchasing an additional 4,189,805 shares in the last quarter. Invesco Ltd. increased its position in BrightSpring Health Services by 47.7% during the 2nd quarter. Invesco Ltd. now owns 9,119,408 shares of the company’s stock valued at $215,127,000 after buying an additional 2,946,811 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in BrightSpring Health Services by 936.4% in the second quarter. The Manufacturers Life Insurance Company now owns 2,276,583 shares of the company’s stock valued at $53,705,000 after buying an additional 2,056,920 shares during the last quarter. Jane Street Group LLC raised its stake in BrightSpring Health Services by 855.4% in the second quarter. Jane Street Group LLC now owns 2,076,730 shares of the company’s stock valued at $48,990,000 after buying an additional 1,859,369 shares during the last quarter. Finally, 8 Knots Management LLC acquired a new stake in BrightSpring Health Services in the third quarter worth about $51,244,000.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.